As these patients were most likely classified as moderate progressors, the results suggested that 50 mg methylcobalamin injections could be beneficial for patients with ALS in the early stage and with moderate progression rate, the researchers wrote
Switching the injection type from subcutaneous to intramuscular
Additionally, patients with inflammatory bowel disease, severe gastroesophageal reflux disease, or other significant gastrointestinal disorders should be monitored closely if treatment is initiated, as the gastrointestinal effects of semaglutide may worsen their underlying condition
Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P
This can reduce its potency or render it completely inactive, which would invalidate your research data
However, results vary